Back to search

Article

EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL

2021-09-20

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> COVID-19 is still a challenge, both with regard to its treatment and to the actual efficacy of the vaccines available to date, especially with the emergence of new variants. We evaluated the efficacy of the measles-mumps-rubella (MMR) vaccine in preventing SARS-CoV-2 infection and severity of COVID-19 in health workers. <h4>Methods</h4> This analysis includes data from one...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1d3f86b4-018b-541f-b7cc-7a4c00ad8b4d
DOI
10.1101/2021.09.14.21263598
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIALDOI 10.1101/2021.09.14.21263598
Select a neighboring publication to make it the new centre.